An international clinical trial on the efficacy and safety of roxithromycin in 40,000 patients with acute community-acquired respiratory tract infections
- 30 June 1992
- journal article
- clinical trial
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (4) , 81-84
- https://doi.org/10.1016/0732-8893(92)90132-d
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Macrolide pharmacokinetics and dose scheduling of roxithromycinDiagnostic Microbiology and Infectious Disease, 1992
- Roxithromycin: a pharmacokinetic review of a macrolideJournal of Antimicrobial Chemotherapy, 1987
- Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overviewJournal of Antimicrobial Chemotherapy, 1987
- In-vitro activity of roxithromycin against respiratory and skin pathogensJournal of Antimicrobial Chemotherapy, 1987
- In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984